dr. choueiri on fda approval of cabozantinib for rcc
Published 8 years ago • 529 plays • Length 1:06Download video MP4
Download video MP3
Similar videos
-
0:45
dr. choueiri on fda approval of lenvatinib/everolimus in rcc
-
0:52
dr. choueiri on the role of cabozantinib in rcc
-
0:29
dr. mckay on fda approval of frontline cabozantinib in rcc
-
1:08
dr. choueiri on the biology of the cabosun trial for rcc
-
1:20
dr. choueiri on overall findings of cabosun trial for rcc
-
0:41
dr. toni choueiri on cabozantinib and nivolumab combination in kidney cancer
-
0:52
dr. choueiri on impact of cabosun results in renal cell carcinoma
-
1:44
dr. choueiri on cabosun trial results in rcc
-
1:45
dr. choueiri on cabosun trial results for rcc
-
1:35
dr. toni choueiri on cabozantinib versus everolimus in renal cell carcinoma
-
1:41
dr. choueiri on next steps for treatment in rcc
-
1:52
dr. choueiri on using immunotherapy to treat rcc
-
1:18
dr. abou-alfa on the fda approval of cabozantinib in hcc
-
1:47
dr. choueiri discusses immunotherapy in rcc
-
1:40
dr. powles on fda approval of pembrolizumab plus axitinib in advanced rcc
-
1:10
dr. mcdermott on the promise of pembrolizumab in non-clear cell rcc
-
1:33
dr. choueiri on the next generation of trials in rcc
-
1:06
dr. choueiri on atezolizumab plus bevacizumab in non–clear cell rcc
-
1:02
dr. choueiri discusses the current state of rcc treatment